TRUMENBA, suspension for injection in a pre-filled syringe. meningococcal vaccine group B (recombinant, adsorbed) syringe, 0.5 ml
Active ingredients: FHBP DE LA SOUS-FAMILLE A DE NEISSERIA MENINGITIDIS DE SÉROGROUPE B, FHBP DE LA SOUS-FAMILLE B DE NEISSERIA MENINGITIDIS DE SÉROGROUPE B
Commercialized according to BDPMDispensing in France: Prescription only
Suspension for injectionsyringe, 0.5 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TRUMENBA, suspension injectable en seringue préremplie. Vaccin méningococcique groupe B (recombinant, adsorbé)
- Pharmaceutical form
- suspension injectable
- Route of administration
- intramusculaire
- Presentation description
- 1 seringue préremplie en verre de 0,5 ml avec aiguille
- Marketing authorisation holder
- PFIZER EUROPE MA EEIG (BELGIQUE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Sept 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65802140CIP73009637CIP133400930096376Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FHBP DE LA SOUS-FAMILLE A DE NEISSERIA MENINGITIDIS DE SÉROGROUPE Bsuspension | 60 microgrammes · une dose de 0,50 ml | SA |
| FHBP DE LA SOUS-FAMILLE B DE NEISSERIA MENINGITIDIS DE SÉROGROUPE Bsuspension | 60 microgrammes · une dose de 0,50 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.